Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| PF-06747775 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. |  |
| PF-06747775 | PF-06747775, a methylpurin derivative, has been found to be an epidermal growth factor receptor antagonist and could probably be effective against cell lung cancer through restrain EGFR-mediated signaling. It is still under Phase-I trial in Non-small cell lung cancer. Synonyms: YXX2180047; Egfr T790M inhibitor PF-06747775; PF-06747775; N-[(3R,4R)-4-fluoro-1-[6-[(3-methoxy-1-methylpyrazol-4-yl)amino]-9-methylpurin-2-yl]pyrrolidin-3-yl]prop-2-enamide. Grades: 98%. CAS No. 1776112-90-3. Molecular formula: C18H22FN9O2. Mole weight: 415.43. |  |
| Mavelertinib | Mavelertinib is a selective, orally available and irreversible EGFR tyrosine kinase inhibitor (EGFR TKI), with IC50s of 5, 4, 12 and 3 nM for Del, L858R, and double mutants T790M/L858R and T790M/Del, respectively. Mavelertinib can be used for the research of non-small-cell lung cancer (NSCLC)[1][2][3][4]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: PF-06747775. CAS No. 1776112-90-3. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-12972. |  |
Our database is helping our users find suppliers everyday.
